Goodwin Procter LLP advised Nimbus Therapeutics on the deal.Nimbus Therapeutics announced the closing of a $105 million private financing round which was led by BVF Partners L.P….
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
